Medication info

CoviTakan Tablets

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Hanwha Pharmaceutical Co., Ltd.
Appearance
Light pink, biconvex, rectangular tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 200902090 · Notified 2009.03.20

This product's status changed to Approval withdrawn on 2023.11.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with individual-component therapy
Who takes it
Adults
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this drug. When clinically appropriate, a direct switch from monotherapy to this drug may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this drug is necessary in elderly patients. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this drug (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this drug to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Hanwha Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with individual-component therapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension whose treatment with individual components is insufficient.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this drug. When clinically appropriate, a direct switch from monotherapy to this drug may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this drug is necessary in elderly patients. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this drug (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this drug to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This medication can cause serious harm to the fetus and newborn, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used by individuals allergic to this medication's ingredients or sulfonamide drugs, pregnant women or those planning to become pregnant, breastfeeding individuals, those with severe renal or hepatic dysfunction, patients with a history of certain angioedema, or gout patients. Patients with decreased blood volume or sodium deficiency, liver disease, heart valve disease, hyperkalemia, the elderly, etc., should use this medication cautiously and consult a physician before use. During treatment, various side effects such as headache, dizziness, fatigue, dyspepsia, and skin rash may occur; immediately report to medical personnel if symptoms are severe or persistent. Due to the strong hypotensive effect, especially when taken with other antihypertensive medications, there is a risk of blood pressure dropping too low, so regular monitoring of blood pressure and blood tests should be conducted to assess renal function and electrolyte levels periodically. This medication can affect potassium levels; therefore, when taken with potassium supplements or potassium-sparing diuretics, potassium concentrations should be monitored carefully. If surgery or anesthesia is planned, inform medical personnel beforehand as this medication can affect blood pressure, and it may be necessary to temporarily discontinue its use. Safety and efficacy for children and adolescents under 18 years of age have not been established, so its use is not recommended. In case of overdose, symptoms such as hypotension, dizziness, and electrolyte imbalance may appear, in which case immediate medical treatment is required. This medication should be stored out of reach of children and kept in its original container to prevent degradation and misuse. Caution is advised when driving or operating machinery, as dizziness or fatigue may occur.

Side effects

Headache, back pain, dizziness, respiratory tract infection, symptoms similar to influenza, sinusitis, bronchitis, urinary tract infection, nausea, contusion, tachycardia, fatigue, abdominal pain, pharyngitis, atrioventricular block, vomiting, dyslipidemia, rhinitis, cough, increased blood sugar, elevated serum uric acid, increased ALT, decreased hemoglobin, increased serum AST, increased creatinine, elevated urea, increased potassium, decreased sodium, leukopenia, neutropenia, agranulocytosis, dizziness, diarrhea, renal failure, angioedema, rash, urticaria, pruritus, arthralgia, myalgia, hyperkalemia, hyponatremia, increased liver enzyme levels, abnormal liver function, hepatitis, cardiac arrhythmia, sensory disturbances, blurred vision, choroidal exudate, acute myopia, acute angle-closure glaucoma, dyspnea, acute respiratory distress syndrome, loss of appetite, appetite loss, gastrointestinal irritation, constipation, pancreatitis, interstitial nephritis, rash, photosensitivity reaction, toxic epidermal necrolysis, reaction resembling erythema multiforme lupus, activation of erythema multiforme lupus, muscle cramps, hyperglycemia, hyperuricemia, electrolyte imbalance, orthostatic hypotension, necrotizing vasculitis, weakness, fever, anaphylactic reaction, jaundice, sleep disturbances, depression, anxiety, edema, pain, myalgia, hypercalcemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container, protected from air and moisture, and kept in a cool place below 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Light pink, biconvex, rectangular tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.